Comparative Effectiveness Research: 21st Century Health Care - PowerPoint PPT Presentation

1 / 40
About This Presentation
Title:

Comparative Effectiveness Research: 21st Century Health Care

Description:

Translating scientific advances into actual clinical practice ... Medical Expenditures. Annual Quality & Disparities Reports. Safety & Quality Measures, ... – PowerPoint PPT presentation

Number of Views:50
Avg rating:3.0/5.0
Slides: 41
Provided by: carolyncla9
Category:

less

Transcript and Presenter's Notes

Title: Comparative Effectiveness Research: 21st Century Health Care


1
Comparative Effectiveness Research 21st Century
Health Care
  • Carolyn M. Clancy, MD
  • Agency for Healthcare Research and Quality
  • Penn State University College of Medicine
  • July 31, 2009

2
(No Transcript)
3
Health Care Reform in the Current Economic
Environment
59
37
It is more important than ever to take on health
care reform now
We cannot afford to take on health care reform
right now
4
Kaiser Family Foundation Health Tracking Poll
(Conducted (April 2-8, 2009)
Dont Know/Refused
4
More Say Reform Would Help
Country
Do you think (you and your family/the country as
a whole) would be better off if the president and
Congress passed health care reform, or dont you
think it would make much difference?
Kaiser Family Foundation Health Tracking Poll
(Conducted April 2-8, 2009)
5
Current Challenges
  • Concerns about health spending about 2.3
    trillion per year in the U.S. and growing
  • Large variations in clinical care
  • A lot of uncertainty about best practices
    involving treatments and technologies
  • Pervasive problems with the quality of care that
    people receive
  • Translating scientific advances into actual
    clinical practice
  • Translating scientific advances into usable
    information for clinicians and patients

6
Comparative Effectiveness Research
  • AHRQ Resources Priorities
  • Comparative Effectiveness Research
  • Comparative Effectiveness and Health IT
  • QA

7
HHS Secretary Kathleen Sebelius
  • It is an honor to lead the Department of Health
    and Human Services and I am grateful for the
    opportunity to serve at such a pivotal moment in
    our history

Kathleen Sebelius
Sworn in as the 21st Secretary of the Department
of Health and Human Services
April 29, 2009
8
HHS Organizational Focus
NIH Biomedical research to prevent, diagnose and
treat diseases
CDC Population health and the role of
community-based interventions to improve health
AHRQ Long-term and system-wide improvement of
health care quality and effectiveness
9
AHRQs Mission
Improve the quality, safety, efficiency and
effectiveness of health care for all Americans
10
AHRQ Roles and Resources
  • Health IT Research
  • Funding
  • Support advances that improve patient
    safety/quality of care
  • Continue work in hospital settings
  • Step up use of HIT to improve ambulatory patient
    care
  • Develop Evidence Base for Best Practices
  • Four key domains
  • Patient-centered care
  • Medication management
  • Integration of decision support tools
  • Enabling quality measurement
  • Promote Collaboration
  • and Dissemination
  • Support efforts of AHIC, ONC, HRSA and Centers
    for Medicare and Medicaid Services
  • Build on public and private partnerships
  • Use web tools to share knowledge and expertise

11
AHRQ FY 2009 Funding
  • 372 million
  • 37 million more than FY 2008
  • 46 million more than the presidents request
  • FY 2009 appropriation includes
  • 50 million for comparative effectiveness
    research, 20 million more than FY 2008
  • 49 million for patient safety activities
  • 45 million for health IT

12
AHRQ Priorities
Patient Safety
  • Health IT
  • Patient SafetyOrganizations
  • New PatientSafety Grants

Effective HealthCare Program
AmbulatoryPatient Safety
  • Comparative Effectiveness Reviews
  • Comparative Effectiveness Research
  • Clear Findings for Multiple Audiences
  • Safety Quality Measures,Drug Management
    andPatient-Centered Care
  • Patient Safety ImprovementCorps

Medical ExpenditurePanel Surveys
Other Research Dissemination Activities
  • Visit-Level Information on Medical Expenditures
  • Annual Quality Disparities Reports
  • Quality Cost-Effectiveness, e.g.Prevention and
    PharmaceuticalOutcomes
  • U.S. Preventive ServicesTask Force
  • MRSA/HAIs

13
Multi-Media Campaigns Get Patients Involved
  • AHRQ expands Ad Council campaign with a new
    series of TV and radio public service
    announcements along with printed consumer
    resources

http//www.ahrq.gov/questionsaretheanswer
14
AHRQs Latest Reports on Quality and Disparities
  • The median annual rate of change for all quality
    measures was 1.4
  • Of 190 measures, 132 (69) showed some
    improvement
  • Some reductions in disparities of care according
    to race, ethnicity, income
  • Disparities persist in health care quality and
    access

15
Quality Report Key Findings
  • Median level of patients receiving needed care
    was 59 for core quality measures
  • Quality improvements spread unevenly across
    settings of care (hospitals, home care, long-term
    care, ambulatory care)
  • Measures of patient safety in the Quality Report
    indicate a 1 annual decline
  • Need consensus on single core set of measures to
    be used by all payers and stakeholders to monitor
    improvement

16
Disparities Report Key Findings
  • 60 of measures of quality are not improving for
    Blacks, Asians, American Indians/Alaska Natives
    (AI/AN), Hispanics, poor populations trend for 6
    years
  • 80 of access measures stayed the same or got
    worse for Hispanics
  • 60 of access measures stayed the same or got
    worse for Blacks and Asians
  • 57 of access measures stayed the same or got
    worse for poor populations

17
PA Overall Health Care Quality
Performance vs. All States, One-Year Performance
Change
Average
Weak
Strong
Very Weak
Very Strong
Performance Meter
2008 National Healthcare Quality Report, State
Snapshots
18
Pennsylvania Snapshot
National Healthcare Quality Report, State
Snapshots, 2008
19
Comparative Effectiveness Research
  • AHRQ Resources Priorities
  • Comparative Effectiveness Research
  • Comparative Effectiveness and Health IT
  • QA

20
U.S. Landscape for Comparative Effectiveness
Research
  • Well intentioned
  • Ad hoc except for AHRQs mandate
  • Limited capacity to do the research and translate
    the research into meaningful and useable
    applications

21
Comparative Effectiveness
and the Recovery Act
  • The American Recovery and Reinvestment Act of
    2009 includes 1.1 billion for comparative
    effectiveness research
  • AHRQ 300 million
  • NIH 400 million (appropriated to AHRQ and
    transferred to NIH)
  • Office of the Secretary 400 million (allocated
    at the Secretarys discretion)

www.hhs.gov/recovery
22
Other Aspects of
the Recovery Act
  • Comparative Effectiveness Research conducted with
    funds appropriated under the Recovery Act, shall
    be consistent with Departmental policies relating
    to the inclusion of women and minorities.
  • Congress does not intend for the research money
    to be used to mandate coverage reimbursement or
    other policies for any public or private payer.
  • Details about the types of research being funded
    or supported must be submitted to Congress every
    six months, beginning Nov. 1, 2009

www.hhs.gov/recovery
23
Recovery Act Timeline AHRQ
May 1 Due date for Agency wide and
program-specific Recovery Act plans
July 30 AHRQ to submit FY 09 Operations
Plan
December 31, 2010 All Recovery Act funding to be
obligated
February 17 The American Recovery and
Reinvestment Act of 2009 is signed into law
2009
January
April
July
October
2010
November 1 AHRQ FY 10 operations plan
due
March 19 The Federal Coordinating Council for
Comparative Effectiveness Research is established
June 30 Due date for IOM submission of a list of
national priority conditions
Stakeholder input required
24
Federal Coordinating Council
  • Anne Haddix, CDC
  • Thomas Valuck, CMS
  • Peter Delany, SAMHSA
  • Carolyn Clancy, AHRQ
  • Deborah Hopson, HRSA
  • David Hunt, ONC
  • James Scanlon, HHS
  • Garth Graham, Office of Minority Health
  • Elizabeth Nabel, NIH
  • Jesse Goodman, FDA
  • Michael Marge, Office on Disability
  • Neera Tanden, HHS
  • Joel Kupersmith, VA
  • Michael Kilpatrick, DoD
  • Ezekiel Emanuel, OMB

25
Definition Comparative Effectiveness Research
  • Comparative effectiveness research (CER) is the
    generation and synthesis of evidence that
    compares the benefits and harms of alternative
    methods to prevent, diagnose, treat and monitor a
    clinical condition or to improve the delivery of
    care. The purpose of CER is to assist consumers,
    clinicians, purchasers and policy makers to make
    informed decisions that will improve health care
    at both the individual and population levels.
  • National Priorities for Comparative Effectiveness
    Research
  • Institute of Medicine Report Brief
  • June 2009

26
IOM Priorities for Comparative Effectiveness
Research
  • 100 recommendations listed in four groups of 25,
    ranging from highest to lowest priority
  • Includes the Federal Coordinating Councils
    definition of comparative effectiveness research
  • Key elements of the definition
  • Direct comparison of effective interventions
  • Study of patients in typical day-to-day clinical
    care
  • Tailoring decisions to the needs of individual
    patients

Report Brief Available At http//www.iom.edu
27
AHRQs Role in Comparative
Effectiveness
Using Information to Drive Improvement
Scientific Infrastructure to Support Reform
Providing information that can be used on the
frontlines of treatment
  • Helping to make decisions more consistent,
    transparent and rational

Promoting an open and collaborative approach to
comparative effectiveness
Ensuring the effectiveness data is more widely
used
28
The Effective Health Care Program at AHRQ
  • Evidence synthesis (EPC program)
  • Systematically reviewing, synthesizing, comparing
    existing evidence on treatment effectiveness
  • Identifying relevant knowledge gaps
  • Evidence generation (DEcIDE, CERTs)
  • Development of new scientific knowledge to
    address knowledge gaps.
  • Accelerate practical studies
  • Evidence communication/translation (Eisenberg
    Center)
  • Translate evidence into improvements
  • Communication of scientific information in plain
    language to policymakers, patients, and providers

29
Transparent Collaborative Process with New
Opportunities
  • Expanded infrastructure and capacity for
    Comparative Effectiveness Research
  • Prospective studies that include
    under-represented populations
  • Pushing forward on methods for Comparative
    Effectiveness Research
  • Increasing investments in innovative broad
    dissemination and translation

30
Comparative Effectiveness Funding Opportunities
  • Opportunities for the field to become involved
    will be made available as soon as possible
  • To sign up for updates, visit http//effectiveheal
    thcare.ahrq.gov
  • To review AHRQs standing program and training
    award announcements http//www.ahrq.gov/fund/grant
    ix.htm

31
Comparative Effectiveness Research
  • AHRQ Resources Priorities
  • Comparative Effectiveness Research
  • Comparative Effectiveness and Health IT
  • QA

32
Health IT and Comparative Effectiveness Research
  • As with comparative effectiveness research,
    health IT is a useful tool in a much larger
    toolkit it is necessary, but not the solution.
    With regards to comparative effectiveness
    research, health IT can play pivotal roles. For
    example
  • Information gathering technology has the
    potential to enable studies to be completed
    much, much faster
  • Dissemination Results about
    new findings can be widely
    distributed very quickly

33
AHRQ Health IT Research Funding
  • Long-term agency priority
  • AHRQ has invested more than 260 million in
    contracts and grants
  • More than 150 communities, hospitals, providers,
    and health care systems in 48 states

http//healthit.ahrq.gov
34
Meaningful Use
  • The Recovery Act calls for establishment of an
    incentive for providers who become meaningful
    users of electronic health records
  • A Federal Health IT Policy Committee workgroup is
    developing criteria for a definition of
    meaningful use
  • AHRQ provides Federal partners with the best
    available evidence on how proposed criteria for
    meaningful use might help to achieve the ultimate
    goal of high quality, high value health care

http//healthit.hhs.gov
35
Health IT EPC Report
  • First synthesis of existing evidence on factors
    influencing the usefulness, usability, barriers
    and drivers to use, and effectiveness of consumer
    applications
  • The top factor associated with use by patients
    was the perception of a health benefit
  • Patients prefer systems tailored to them that
    incorporate familiar devices

36
Distributed Network Prototypes for
Population-Based Studies
  • Aim to develop a federated network prototype
    that supports secure analyses of electronic
    information across multiple organizations to
    study risks, effects and outcomes of various
    medical therapies
  • The long-term goal is a coordinated partnership
    of multiple research networks that provide
    information that can be quickly queried and
    analyzed
  • Model 1 Colorado DEcIDE center with American
    Academy of Family Practice will develop the
    Distributed Ambulatory Research Network
    (DARTNet) using electronic health record (EHR)
    data from eight organizations representing over
    200 clinicians and over 350,000 patients
  • Model 2 HMO Research Network (HMORN) DEcIDE will
    develop the Virtual Data Warehouse to assess
    the effectiveness and safety of different
    anti-hypertensive 5.5 to 6 million individuals
    cared for by six health plans

AHRQ Centers for Outcomes and Evidence
37
Research Opportunities
  • Health IT Funding Opportunities
  • PAR-08-270 Utilizing Health Information
    Technology (IT) to Improve Health Care Quality
    (R18)
  • PAR-08-269 Exploratory and Developmental Grant to
    Improve Health Care Quality through Health
    Information Technology (IT) (R21)
  • PAR-08-268 Small Research Grant to Improve Health
    Care Quality through Health Information
    Technology (IT) (R03)

38
Moving Forward
Issues to Consider
  • Comparative Effectiveness is a useful tool in a
    much larger toolkit it is necessary but not
    sufficient
  • It does not make policy or health care decisions,
    tell doctors how to practice medicine or make
    final decisions about what kind of treatments
    insurers will pay for
  • It does weigh the evidence and present it in a
    way that helps consumers and their doctors make
    the best possible decisions about health care
    choices
  • Its also an opportunity to identify what is not
    known/areas where research is needed

39
Comparative Effectiveness Research
  • Public-private funding and participation likely a
    necessity
  • More effort to get better conditional
    reimbursement study designs/protocols
  • Patients should be engaged as partners at the
    local and national levels
  • Need to tackle important issues
  • Ethical
  • When to know when the evidence is sufficient
  • Transparency
  • Setting priorities

40
Comparative Effectiveness Research
  • AHRQ Resources Priorities
  • Comparative Effectiveness Research
  • Comparative Effectiveness and Health IT
  • QA
Write a Comment
User Comments (0)
About PowerShow.com